Here are relevant reports on : cerebral-infarction-therapy-market
-
Cardiac Rhythm Management Market by Product (Implantable, External Pacemakers, Defibrillators, Cardiac resynchronization therapy (CRT) devices), by End-Users (Hospitals, Home, Ambulatory) Forecasts To 2020
The incidence of cardiovascular diseases (CVD) is increasing with the aging population, changing lifestyle, and increasing stress. It is estimated that 17 million people die of CVD every year. Sudden cardiac arrest (SCA) is the leading cause of death among U.S. adults aged 40 years and above. According to Centre for Disease Control and Prevention (CDC), approximately 250,000 people die every year in the U.S. from SCA.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
CAR T-cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target Antigen (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), End User & Region - Global Forecast to 2029
The global CAR T-cell therapy market, valued at US$3.7 billion in 2023, stood at US$5.5 billion in 2024 and is projected to advance at a resilient CAGR of 39.6% from 2024 to 2029, culminating in a forecasted valuation of US$29.0 billion by the end of the period. The growth of this market due to the rise in investments and funding for CAR T-cell therapy developments and technological advancements in CAR T-cell therapy.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - - Global Forecast to 2021
The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand. The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cell Therapy Technologies Market by Product (Media, Sera, Reagents, Vessels, Equipment), Process (Expansion, Isolation, Characterization, Collection, Preservation, Distribution, QC), Type (T-cells, Stem Cells), Application (Cancer) - Global Forecast to 2030
The global cell therapy technologies market, valued at US$4.05 billion in 2024, stood at US$4.41 billion in 2025 and is projected to advance at a resilient CAGR of 12.4% from 2024 to 2030, culminating in a forecasted valuation of US$7.91 billion by the end of the period.
- Published: December 2025
- Price: $ 4950
- TOC Available:
-
Negative Pressure Wound Therapy Market by Product (Conventional, Single-use NPWT, Consumables, Accessories), Wound Type (Burns, Surgical, Traumatic, Diabetic Foot, Pressure, Venous Leg Ulcers), End User (Hospitals, Homecare) - Global Forecast to 2030
Global negative pressure wound therapy market valued at $2.59B in 2024, reached $2.76B in 2025, and is projected to grow at a robust 6.9% CAGR, hitting $3.84B by 2030. The growth potential of emerging countries and cost effectiveness of negative pressure wound therapy products also poses an opportunistic factor for market growth.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Cryo-electron Microscopy Market by Product & Service (Instruments, Software, Services), Technology (Electron Crystallography, Cryo-ET), Voltage (300 kV), Application (Cancer, Omics, Gene Therapy, Nanotechnology, Vaccine) & Region - Global Forecasts to 2028
The global cryo-electron microscopy market in terms of revenue was estimated to be worth $1.1 billion in 2022 and is poised to reach $2.1 billion by 2028, growing at a CAGR of 11.6% from 2022 to 2028. As of 2021, prominent players in the global market are Thermo Fisher Scientific (US), Danaher (US), JEOL Ltd. (Japan), Intertek Group Plc (UK), and Charles River Laboratories (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
AI in Precision Medicine Market by Application (Drug Discovery, Screening, Diagnosis, Stratification, Staging, Prognosis, Therapy Selection, Monitoring, Risk Management), Indication (Cancer, CNS, CVS), Tools (ML, NLP), & End User -Global Forecast to 2030
The global AI in Precision Medicine market, valued at US$0.60 billion in 2023, stood at US$0.78 billion in 2024 and is projected to advance at a resilient CAGR of 30.7% from 2024 to 2030, culminating in a forecasted valuation of US$3.92 billion by the end of the period. Growth in precision medicine, AI’s efficiency in drug discovery, integration of Real-World Evidence (RWE) in emerging markets to drive the market significantly.
- Published: November 2024
- Price: $ 4950
- TOC Available:
-
Gold Nanoparticles Market by Process (Physical, Chemical, Biological), Application (Imaging, Targeted Drug Delivery, Proton Therapy, In-Vitro Assays, Sensors, Probes, Catalysis), End-Use Industry and Region - Global Forecast to 2029
The gold nanoparticles market is expected to grow from USD 0.50 billion in 2024 to USD 1.11 billion in 2029, at a CAGR of 16.3% during the forecast period. Prominent companies include BBI Solutions (UK), Cytodiagnostics Inc (Canada), Fortis Life Sciences, LLC. (US), Meliorum Technologies, Inc (US), TANAKA PRECIOUS METAL GROUP Co., Ltd. (Japan), Merck KGaA (Germany), Nanopartz, Inc (US), CD Bioparticles (US), Nano Labs (India), Nanocs Inc. (US), NanoHybrids (US), Sona Nanotech (Canada), Sisco Research Laboratories Pvt, Ltd. (India), Nanoprobes, Inc (US), American Elements (US), TORSKAL (France), Abcam Limited (UK), Particular GmbH (Germany), Dongguan Sat Nano Technology Material Co., Ltd (China), Nano Flow (Belgium), Strem Catalog (US), Nanorh (India), SkySpring Nanomaterials (US), Aurion (Netherlands), NNCrystal US Corporation (US), and among others.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Contract Manufacturing Market by Service (Manufacturing, Fill-Finish), Type (Drug Substance, Drug Product), Scale (Clinical), Source (Mammalian), Therapy Area (Oncology), Molecule Type (mAbs, ADC, CGT, Vaccines) - Global Forecast to 2030
The global biopharmaceutical contract manufacturing market, valued at US$20.51 billion in 2024, stood at US$22.40 billion in 2025 and is projected to advance at a resilient CAGR of 8.8% from 2025 to 2030, culminating in a forecasted valuation of US$34.15 billion by the end of the period. The growth is primarily driven by the rising demand for outsourcing services and an increasing need for biologics and biosimilars. However, challenges related to intellectual property rights are anticipated to pose barriers to market growth.
- Published: July 2025
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
